I agree that this site is using cookies. You can find further informations here.
X
Wasan, Harpreet Singh
139  results:
Search for persons X
?
1

Second-line FOLFOX chemotherapy versus active symptom contr..:

Lamarca, Angela ; Palmer, Daniel H ; Wasan, Harpreet Singh...
The Lancet Oncology.  22 (2021)  5 - p. 690-701 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Results of a single-arm pilot study of 32P microparticles i..:

Ross, Paul ; Wasan, Harpreet Singh ; Croagh, Daniel...
uri/info:doi/10.1016/j.esmoop.2021.100356.  , 2022
Link: http://hdl.handle.net/20..
 
?
3

Second-line FOLFOX chemotherapy versus active symptom contr..:

Lamarca, Angela ; Palmer, Daniel H ; Wasan, Harpreet Singh...
Lamarca , A , Palmer , D H , Wasan , H S , Ross , P J , Ma , Y T , Arora , A , Falk , S , Gillmore , R , Wadsley , J , Patel , K , Anthoney , A , Maraveyas , A , Iveson , T , Waters , J S , Hobbs , C , Barber , S , Ryder , W D , Ramage , J , Davies , L M , Bridgewater , J A & Valle , J W 2021 , ' Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial ' , The Lancet Oncology , vol. 22 , no. 5 , pp. 690-701 . https://doi.org/10.1016/S1470-2045(21)00027-9.  , 2021
Link: https://research.manches..
 
?
4

Second-line FOLFOX chemotherapy versus active symptom contr..:

Lamarca, Angela ; Palmer, Daniel H ; Wasan, Harpreet Singh...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082275/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Second-line FOLFOX chemotherapy versus active symptom contr..:

Lamarca, Angela ; Palmer, Daniel H ; Wasan, Harpreet Singh...
https://eprints.soton.ac.uk/452333/1/1_s2.0_S1470204521000279_main.pdf.  , 2021
Link: https://eprints.soton.ac..
 
?
6

Consensus statement on safety of combining transarterial ra..:

Kennedy, Andrew S. ; Brown, Daniel B. ; Fakih, Marwan...
Journal of Vascular and Interventional Radiology.  , 2024
Link: https://doi.org/10.1016/..
 
?
7

Optimal maintenance strategy following FOLFOX plus anti-EGF..:

Raimondi, Alessandra ; Nichetti, Federico ; Stahler, Arndt...
European Journal of Cancer.  190 (2023)  - p. 112945 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Immediate surgery compared with short-course neoadjuvant ge..:

Ghaneh, Paula ; Palmer, Daniel ; Cicconi, Silvia...
The Lancet Gastroenterology & Hepatology.  8 (2023)  2 - p. 157-168 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Is antibody-drug conjugate a rising star for clinical treat..:

Zhang, Leyin ; Shen, Deyi ; Yu, Lulin...
Critical Reviews in Oncology/Hematology.  177 (2022)  - p. 103758 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal T..:

Yuan, Li ; Zhang, Kai ; Zhou, Meng-Meng...
Journal of Cancer.  13 (2022)  15 - p. 3713-3715 , 2022
Link: https://doi.org/10.7150/..
 
?
11

Causes of Death After Colorectal Cancer Diagnosis: A Popula..:

Feng, Yuqian ; Jin, Huimin ; Guo, Kaibo...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
12

Transcription factor POU4F2 promotes colorectal cancer cell..:

Guo, Kaibo ; Wang, Peipei ; Zhang, Leyin...
Cancer Science.  112 (2021)  10 - p. 4176-4186 , 2021
Link: https://doi.org/10.1111/..
 
?
13

Association of Survival and Immune-Related Adverse Events W..:

Zhang, Leyin ; Sun, Leitao ; Zhou, Yiwen...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
14

Resveratrol and Its Analogs: Potent Agents to Reverse Epith..:

Guo, Kaibo ; Feng, Yuqian ; Zheng, Xueer...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
15

PanCO: Updated Results of an Open-Label, Single-Arm Pilot S..:

Ross, Paul ; Hendlisz, Alain ; Ajithkumar, Thankamma...
Pancreatology.  20 (2020)  8 - p. e16 , 2020
Link: https://doi.org/10.1016/..
 
1-15